🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Japan Topix Hits 30-Year High: ETFs to Tap

Published 09/02/2021, 11:10 PM
Updated 07/09/2023, 06:31 AM
GS
-
TOPX
-

After underperforming for several months, Japan stocks have gained momentum lately on hopes of a stronger government ahead of a ruling party leadership race and a general election in November.

The resignation of Prime Minister Yoshihide Suga has opened the door for the new government, which will likely unveil an economic package to support pandemic-hit businesses and families. As such, the move has spurred bets for strong economic recovery by the end of the year. Notably, the Japan Topix Index climbed to the highest level since April 1991 and has been outperforming its Asian peers in recent weeks.

The gains were also driven by record earnings and rising vaccination rates. Per Reuters, the forward EPS of MSCI Japan has risen 30% so far this year, outpacing other major markets including the United States, giving Japanese shares an edge after their underperformance earlier this year (read: 5 Top-Ranked ETFs That Outperformed in August).

Meanwhile, vaccinations have surged from just 3% of Japan’s population at the start of June to 45% population by the end of August. The world’s third-largest economy is expected to surpass the United States, which currently has fully vaccinated around 52% of its population, in the next few weeks. Additionally, about 90% of seniors in Japan are fully vaccinated, more than in many countries that started their campaigns much earlier.

Further, Japan’s economy roared back to life in the second quarter with GDP rising 0.3% on a quarter-over-quarter basis after a 0.9% drop in the first quarter. The economy grew 1.3% in an annualized basis on the reopening of businesses but is slower than the other developed economies given that a sudden rise in COVID-19 cases took a toll on growth. Japan is battling its largest-ever surge in COVID-19 cases, with an increase of 20,000 in new infections daily.

Given the higher expectation of a leadership change and the resultant economic growth, investors seeking to participate in the stock rally should definitely invest in Japan ETFs. While most ETFs have been delivering handsome returns in the past week, we have highlighted the ones that are crushing the broad market fund SPY and the ultra-popular Japanese fund EWJ (see: all Developed Asia-Pacific ETFs here).

First Trust Japan AlphaDEX Fund FJP

This fund employs an AlphaDEX methodology to select stocks from the NASDAQ Japan Index. This is easily done by tracking the NASDAQ AlphaDEX Japan Index and the holds a basket of 100 stocks that are widely spread out across various components with each security holding less than 2.7% of assets. Industrials is the top sector with 33.1% share, while consumer discretionary and information technology round out the next two with double-digit exposure each. FJP has AUM of $38.9 million and an average daily volume of around 2,000 shares. Expense ratio comes in at 0.80%. The fund has risen 4.1% in a week and carries a Zacks ETF Rank #3 (Hold) with a Medium risk outlook

Xtrackers Japan JPX-Nikkei 400 Equity ETF JPN

This fund offers exposure to 400 high-quality, capitally-efficient Japanese companies that are screened though indicators such as return on equity, cumulative operating profit and market capitalization. It follows the JPX-Nikkei 400 Net Total Return Index, charging investors 9 bps in annual fees. The ETF has accumulated $18.2 million in its asset base and trades in a paltry volume of 2,000 shares. It has gained 3.4% in a week and carries a Zacks ETF Rank #3 with a Medium risk outlook.

iShares JPX-Nikkei 400 ETF JPXN

This ETF targets Japanese companies that have been screened for profitability and return on equity by tracking the JPX-Nikkei Index 400. It holds well-diversified 395 stocks in its basket with key holdings in industrials at 24.1%. Consumer discretionary, information technology and health care receive the next three spots with double-digit allocation each. The product has AUM of $87.8 million and trades in an average daily volume of 1,000 shares. It charges 48 bps in annual fees and has added 3.3% in a week. The fund has a Zacks ETF Rank #3 with a Medium risk outlook (read: 5 Tech Stocks Leading the Latest Nasdaq ETF Rally).

iShares Currency Hedged JPX-Nikkei 400 ETF HJPX

This is a hedged version of JPXN and offers exposure to broad-based Japanese equities while mitigating exposure to fluctuations between the value of the Japanese yen and U.S. dollar. It has amassed $3.5 million in its asset base and sees a meager volume of just 300 shares a day. It charges 48 bps in fees per year from investors and has gained 3.3% in a week. HJPX has a Zacks ETF Rank #3 with a High risk outlook.

Goldman Sachs (NYSE:GS) ActiveBeta Japan Equity ETF GSJY

This ETF follows the Goldman Sachs ActiveBeta Japan Equity Index, which selects stocks with four distinct performance attributes: good value, strong momentum, high quality and low volatility. It holds 281 stocks in its basket with AUM of $15.2 million and an average daily volume of 2,000 shares. The product has added 3.3% in a week and has a Zacks ETF Rank #3.

Tech IPOs With Massive Profit Potential: Last years top IPOs surged as much as 299% within the first two months. With record amounts of cash flooding into IPOs and a record-setting stock market, this year could be even more lucrative.

See Zacks’ Hottest Tech IPOs Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SPDR S&P 500 ETF (SPY): ETF Research Reports

iShares MSCI Japan ETF (EWJ): ETF Research Reports

iShares JPXNikkei 400 ETF (JPXN): ETF Research Reports

First Trust Japan AlphaDEX ETF (FJP): ETF Research Reports

Goldman Sachs ActiveBeta Japan Equity ETF (GSJY): ETF Research Reports

iShares Currency Hedged JPXNikkei 400 ETF (HJPX): ETF Research Reports

Xtrackers Japan JPXNikkei 400 Equity ETF (JPN): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.